The role of HER family signalling in breast cancer

QR Code

The role of HER family signalling in breast cancer

The HER family of receptors plays a major role in a variety of cancers including breast cancer. Several researchers have shown that HER family overexpression in breast cancer is a significant prognostic factor, especially for survival and relapse. Therefore, many therapeutics are being developed to...

Full description

Bibliographic Details
Main Author:	Kuruppu, Anchala
Format:	Thesis (University of Nottingham only)
Language:	English
Published:	2016
Online Access:	https://eprints.nottingham.ac.uk/33685/

Similar Items

PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer
by: Serra, V., et al.
Published: (2011)

Expression of HER4 isoforms and HER4 localisation in HER2 negative breast cancer cell lines
by: Ali, Nursyazana Aqilah
Published: (2021)

Evaluating the expression of HMGCR in HER2 negative and HER2 positive breast cancer
by: Drahman, Rosmaizan
Published: (2022)

Biological characterisation of HER2 amplified breast cancer
by: Barros, Fabrício Félix Tabuada
Published: (2013)

Adjuvant trastuzumab in HER2-positive breast cancer.
by: Slamon, D., et al.
Published: (2011)

Cytoplasmic and nuclear HER4 expression in HER2 negative breast cancer cell lines
by: Siti Norasikin Mohd Nafi,, et al.
Published: (2022)

Computational pathology and deciphering the complexity of HER2 expression in breast cancer
by: Atallah, Nehal Mohammed
Published: (2025)

Neratinib in HER-2-positive breast cancer: Results to date and clinical usefulness
by: Chan, Arlene
Published: (2016)

Translational control of Human Epidermal Growth Factor Receptors, HER2 and HER4 in response to cellular stresses in breast cancer cells
by: Edwards, Arnelle
Published: (2023)

Inhibition of HER2 enriches for Jagged1-dependent breast cancer stem cells: role for membrane Jagged1
by: Shah, Deep, et al.
Published: (2018)

Neratinib after trastuzumab in patients with HER2-positive breast cancer - Author's reply
by: Chan, Arlene, et al.
Published: (2016)

Bioactivity of black cumin oil on the senescence of HER-2-overexpressing breast cancer cells
by: Faradiba Nur Ahlina,, et al.
Published: (2022)

Her2 challenge contest: a detailed assessment of automated her2 scoring algorithms in whole slide images of breast cancer tissues
by: Qaiser, Talha, et al.
Published: (2018)

HER2 positive metastatic breast cancer: What happens after first line failure?
by: Chan, Arlene
Published: (2016)

Development of sandwich and label-free electrochemical immunosensor for detection of HER2 breast cancer biomarker
by: Lah, Zur Mira Azizah @ Nor Haiza
Published: (2018)

The role of mesenchymal cell-mediated paracrine signalling in breast cancer progression and metastasis
by: Pal, Amarnath
Published: (2019)

Wnt signaling in triple-negative breast cancer
by: Pohl, S., et al.
Published: (2017)

Heightened perception of breast cancer risk in young women at risk of familial breast cancer
by: Glassey, R., et al.
Published: (2017)

Expression of foxp3 tumour infiltrating lymphocytes in her2 positive breast cancer and their association with clinicopathological features
by: Hashim, Sobry
Published: (2023)

An overview of breast cancer: classification and related signaling pathways
by: Chan, Pit Foong, et al.
Published: (2021)

Biological significance of human epidermal growth factor receptor 2 (HER2) in breast cancer: effect of oestrogen receptor
by: Ahmad, Dena Akram Jerjees
Published: (2016)

Mammographic breast density : is there any association with positive family history of breast cancer?
by: Muhammed Nordin, Ellyda, et al.
Published: (2012)

BCL-2, HER1, HER2, HER3 and HER4 expression in primary colorectal adenocarcinoma
by: Ahmad Zubir, Nurul Mahirah
Published: (2017)

Comparison of tumour biomarker HER-2/neu (C-erbB-2) before and after surgery in breast cancer patients
by: Aung, Sanda, et al.
Published: (2014)

Immunohistochemical detection of phospho-Akt, phospho-BAD, HER2 and oestrogen receptors α and β in Malaysian breast cancer patients
by: Seow, Heng Fong, et al.
Published: (2010)

Prevalence and management of HER2/neu-positive early breast cancer in a single institution following availability of adjuvant trastuzumab
by: Chan, Arlene, et al.
Published: (2012)

Phase II, open-label trial of lapatinib and vinorelbine in women with previously treated HER2-positive metastatic breast cancer
by: Chan, Arlene, et al.
Published: (2014)

The role of calpain/calpastatin in breast cancer
by: Cook, Liam
Published: (2024)

Granting specificity for breast cancer cells using a hepatitis B core particle with a HER2-targeted affibody molecule
by: Nishimura, Yuya, et al.
Published: (2011)

Her beauty & her terror : portrait of an archetypal land
by: Frantom, Michelle
Published: (2014)

Oncogenic signaling in tumorigenesis and applications of siRNA nanotherapeutics in breast cancer
by: Nur Izyani K,, et al.
Published: (2019)

It's her platform
by: Lim, Teik Huat
Published: (2018)

Clinical and biological roles of Kelch-like family member 7 in breast cancer: a marker of poor prognosis
by: Kurozumi, Sasagu, et al.
Published: (2018)

The role of polymeric immunoglobulin receptor in breast cancer
by: Asanprakit, Wichitra
Published: (2021)

The role of DARPP-32 in breast cancer progression
by: Saidy, Behnaz
Published: (2022)

The regulatory role of microRNAs in breast cancer
by: Loh, Hui Yi, et al.
Published: (2019)

Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer
by: Miles, D., et al.
Published: (2013)

Investigations into the role of Cten signalling in colorectal cancer
by: Asiri, Abdulaziz
Published: (2018)

Association of DNA methylation status, gene and protein expression of her family in colorectal adenocarcinoma
by: Othman @ Jaffar, Rosfayati
Published: (2020)

microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer
by: Goh, J., et al.
Published: (2015)